Advertisement
ELAN vs VTRS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and VTRS is a Buy.
ELAN's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for ELAN turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on ELAN as a result. In 52 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 172 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 54 cases where ELAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
ELAN moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
ELAN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ELAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.710) is normal, around the industry mean (10.407). P/E Ratio (-55.000) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
VTRS in +6.97% Uptrend, rising for three consecutive days on October 16, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VTRS advanced for three days, in 223 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on VTRS as a result. In 53 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for VTRS just turned positive on October 16, 2026. Looking at past instances where VTRS's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
The 10-day moving average for VTRS crossed bullishly above the 50-day moving average on September 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 195 of 280 cases where VTRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Bearish Trend Analysis
The 10-day RSI Indicator for VTRS moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 19 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
VTRS broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. VTRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.488) is normal, around the industry mean (10.407). P/E Ratio (-49.946) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (3.322) is also within normal values, averaging (2.152). Dividend Yield (0.026) settles around the average of (0.037) among similar stocks. P/S Ratio (1.347) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
ELAN | VTRS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 90 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 35 | |
SMR RATING 1..100 | 92 | 91 | |
PRICE GROWTH RATING 1..100 | 57 | 7 | |
P/E GROWTH RATING 1..100 | 100 | 53 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VTRS's Valuation (16) in the null industry is somewhat better than the same rating for ELAN (58) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew somewhat faster than ELAN’s over the last 12 months.
VTRS's Profit vs Risk Rating (35) in the null industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew somewhat faster than ELAN’s over the last 12 months.
VTRS's SMR Rating (91) in the null industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.
VTRS's Price Growth Rating (7) in the null industry is somewhat better than the same rating for ELAN (57) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew somewhat faster than ELAN’s over the last 12 months.
VTRS's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew somewhat faster than ELAN’s over the last 12 months.
| ELAN | VTRS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 59% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 44% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 68% |
| Advances ODDS (%) | 7 days ago 66% | 7 days ago 74% |
| Declines ODDS (%) | 2 days ago 76% | 10 days ago 64% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 55% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 70% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELAN’s FA Score shows that 0 FA rating(s) are green while VTRS’s FA Score has 2 green FA rating(s).
- ELAN’s FA Score: 0 green, 5 red.
- VTRS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELAN’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 6 bullish TA indicator(s).
- ELAN’s TA Score: 3 bullish, 6 bearish.
- VTRS’s TA Score: 6 bullish, 4 bearish.
Price Growth
ELAN (@Pharmaceuticals: Generic) experienced а -3.61% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +5.79% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.00%. For the same industry, the average monthly price growth was -9.86%, and the average quarterly price growth was +9.31%.
Reported Earning Dates
ELAN is expected to report earnings on Nov 06, 2026.
VTRS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.00% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
VTRS and
Correlation & Price change
A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.
| Ticker / NAME | Correlation To VTRS | 1D Price Change % | ||
|---|---|---|---|---|
| VTRS | 100% | +0.16% | ||
| AMRX - VTRS | 42% Loosely correlated | +1.39% | ||
| COLL - VTRS | 36% Loosely correlated | +2.55% | ||
| AMPH - VTRS | 35% Loosely correlated | -0.61% | ||
| ELAN - VTRS | 34% Loosely correlated | +0.62% | ||
| TEVA - VTRS | 33% Poorly correlated | -1.01% | ||
More | ||||